{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T05:18:04Z","timestamp":1719897484770},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00108-019-00695-x","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T21:41:57Z","timestamp":1572471717000},"page":"1235-1239","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Was ist gesichert in der interventionellen Therapie der peripheren arteriellen Verschlusskrankheit?"],"prefix":"10.1007","volume":"60","author":[{"given":"H.","family":"Krankenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"695_CR1","doi-asserted-by":"publisher","first-page":"e0207456","DOI":"10.1371\/journal.pone.0207456","volume":"13","author":"UO Abaraogu","year":"2018","unstructured":"Abaraogu\u00a0UO, Ezenwankwo\u00a0EF, Dall\u00a0PM et\u00a0al (2018) Living a\u00a0burdensome and demanding life: a qualitative systematic review of the patients experiences of peripheral arterial disease. PLoS ONE 13:e207456","journal-title":"PLoS ONE"},{"key":"695_CR2","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans\u00a0V, Ricco\u00a0JB, Bartelink\u00a0MEL et\u00a0al (2018) 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart\u00a0J 39:763\u2013816","journal-title":"Eur Heart J"},{"key":"695_CR3","doi-asserted-by":"publisher","first-page":"e007055","DOI":"10.1161\/CIRCINTERVENTIONS.118.007055","volume":"11","author":"S Cassese","year":"2018","unstructured":"Cassese\u00a0S, Wolf\u00a0F, Ingwersen\u00a0M et al (2018) Drug-coated balloon angioplasty for femoropopliteal in-stent restenosis. Circ Cardiovasc Interv 11:e7055","journal-title":"Circ Cardiovasc Interv"},{"issue":"1S","key":"695_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","volume":"58","author":"MS Conte","year":"2019","unstructured":"Conte\u00a0MS, Bradbury\u00a0AW, Kolh\u00a0P et al (2019) Global vascular guidelines on the management of chronic limb-threatening Ischemia. Eur J Vasc Endovasc Surg 58(1S):S1\u2013S109.e33","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"695_CR5","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","volume":"133","author":"MD Dake","year":"2016","unstructured":"Dake\u00a0MD, Ansel\u00a0GM, Jaff\u00a0MR et al (2016) Durable clinical effectiveness with paclitaxel-eluting Stents in the femoropopliteal artery: 5\u2011year results of the Zilver PTX randomized trial. Circulation 133:1472\u20131483 (discussion 1483)","journal-title":"Circulation"},{"key":"695_CR6","first-page":"8","volume":"60","author":"K Deloose","year":"2019","unstructured":"Deloose\u00a0K, Martins\u00a0I, Neves\u00a0C et\u00a0al (2019) Endovascular treatment for the common femoral artery: is there a\u00a0challenger to open surgery? J\u00a0Cardiovasc Surg (Torino) 60:8\u201313","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"695_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.avsg.2017.12.003","volume":"50","author":"Y Ding","year":"2018","unstructured":"Ding\u00a0Y, Zhou\u00a0M, Wang\u00a0Y et al (2018) Comparison of drug-eluting stent with bare-metal stent implantation in femoropopliteal artery disease: a systematic review and meta-analysis. Ann Vasc Surg 50:96\u2013105","journal-title":"Ann Vasc Surg"},{"key":"695_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrcardio.2016.179","volume":"14","author":"FG Fowkes","year":"2017","unstructured":"Fowkes\u00a0FG, Aboyans\u00a0V, Fowkes\u00a0FJ et\u00a0al (2017) Peripheral artery disease: epidemiology and global perspectives. Nat Rev Cardiol 14:156\u2013170","journal-title":"Nat Rev Cardiol"},{"key":"695_CR9","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1016\/j.ijcard.2013.06.081","volume":"168","author":"M Fusaro","year":"2013","unstructured":"Fusaro\u00a0M, Cassese\u00a0S, Ndrepepa\u00a0G et al (2013) Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a\u00a0meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison. Int J Cardiol 168:4002\u20134009","journal-title":"Int J Cardiol"},{"issue":"5","key":"695_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/1526602819860124","volume":"26","author":"S Ichihashi","year":"2019","unstructured":"Ichihashi\u00a0S, Shibata\u00a0T, Fujimura\u00a0N et al (2019) Vessel calcification as a risk factor for in-stent restenosis in complex femoropopliteal lesions after Zilver PTX paclitaxel-coated stent placement. J\u00a0Endovasc Ther 26(5):613\u2013620. https:\/\/doi.org\/10.1177\/1526602819860124","journal-title":"J Endovasc Ther"},{"key":"695_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1583\/13-4242.1","volume":"20","author":"JE Indes","year":"2013","unstructured":"Indes\u00a0JE, Pfaff\u00a0MJ, Farrokhyar\u00a0F et al (2013) Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a\u00a0systematic review and meta-analysis. J\u00a0Endovasc Ther 20:443\u2013455","journal-title":"J Endovasc Ther"},{"key":"695_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.avsg.2018.06.002","volume":"53","author":"T Inui","year":"2018","unstructured":"Inui\u00a0T, Deshpande\u00a0R, Lane\u00a0JS et al (2018) External Iliac occlusion does not preclude endovascular management of aortoiliac disease-technique and evolution of therapy. Ann Vasc Surg 53:184\u2013189","journal-title":"Ann Vasc Surg"},{"key":"695_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/bjs.11026","volume":"106","author":"X Jia","year":"2019","unstructured":"Jia\u00a0X, Sun\u00a0ZD, Patel\u00a0JV et\u00a0al (2019) Systematic review of endovascular intervention and surgery for common femoral artery atherosclerotic disease. Br J Surg 106:13\u201322","journal-title":"Br J Surg"},{"key":"695_CR14","first-page":"CD012510","volume":"1","author":"A Kayssi","year":"2019","unstructured":"Kayssi\u00a0A, Al-Jundi\u00a0W, Papia\u00a0G et al (2019) Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries. Cochrane Database Syst Rev 1:CD12510","journal-title":"Cochrane Database Syst Rev"},{"key":"695_CR15","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.jcin.2017.05.015","volume":"10","author":"H Krankenberg","year":"2017","unstructured":"Krankenberg\u00a0H, Zeller\u00a0T, Ingwersen\u00a0M et al (2017) Self-expanding versus balloon-expandable stents for iliac artery occlusive disease: the randomized ICE trial. JACC Cardiovasc Interv 10:1694\u20131704","journal-title":"JACC Cardiovasc Interv"},{"key":"695_CR16","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1007\/s00270-017-1771-5","volume":"40","author":"S M\u00fcller-H\u00fclsbeck","year":"2017","unstructured":"M\u00fcller-H\u00fclsbeck\u00a0S, Keirse\u00a0K, Zeller\u00a0T et al (2017) Long-term results from the MAJESTIC trial of the Eluvia paclitaxel-eluting stent for femoropopliteal treatment: 3\u2011year follow-up. Cardiovasc Intervent Radiol 40:1832\u20131838","journal-title":"Cardiovasc Intervent Radiol"},{"key":"695_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jvs.2016.02.064","volume":"64","author":"BP Mwipatayi","year":"2016","unstructured":"Mwipatayi\u00a0BP, Sharma\u00a0S, Daneshmand\u00a0A et al (2016) Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease. J\u00a0Vasc Surg 64:83\u201394","journal-title":"J Vasc Surg"},{"key":"695_CR18","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.jvs.2015.01.024","volume":"61","author":"BN Nguyen","year":"2015","unstructured":"Nguyen\u00a0BN, Amdur\u00a0RL, Abugideiri\u00a0M et\u00a0al (2015) Postoperative complications after common femoral endarterectomy. J\u00a0Vasc Surg 61:1489\u20131494.e1","journal-title":"J Vasc Surg"},{"key":"695_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","volume":"124","author":"RL Pande","year":"2011","unstructured":"Pande\u00a0RL, Perlstein\u00a0TS, Beckman\u00a0JA et\u00a0al (2011) Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation 124:17\u201323","journal-title":"Circulation"},{"key":"695_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejvs.2017.03.019","volume":"54","author":"M Piazza","year":"2017","unstructured":"Piazza\u00a0M, Squizzato\u00a0F, Dall\u2019Antonia\u00a0A et\u00a0al (2017) Editor\u2019s choice\u2014outcomes of self expanding PTFE covered stent versus bare metal stent for chronic iliac artery occlusion in matched cohorts using propensity score modelling. Eur J Vasc Endovasc Surg 54:177\u2013185","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"695_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1526602814564386","volume":"22","author":"A Rastan","year":"2015","unstructured":"Rastan\u00a0A, Krankenberg\u00a0H, Baumgartner\u00a0I et al (2015) Stent placement vs. balloon angioplasty for popliteal artery treatment: two-year results of a\u00a0prospective, multicenter, randomized trial. J\u00a0Endovasc Ther 22:22\u201327","journal-title":"J Endovasc Ther"},{"key":"695_CR22","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/archsurg.1988.01400310081013","volume":"123","author":"MS Rosenbloom","year":"1988","unstructured":"Rosenbloom\u00a0MS, Flanigan\u00a0DP, Schuler\u00a0JJ et\u00a0al (1988) Risk factors affecting the natural history of intermittent claudication. Arch Surg 123:867\u2013870","journal-title":"Arch Surg"},{"key":"695_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2019.06.038","author":"EM San Norberto","year":"2019","unstructured":"San Norberto\u00a0EM, Flota\u00a0CM, Fidalgo-Domingos\u00a0L et al (2019) Real world results of supera stent implantation for popliteal artery atherosclerotic lesions: 3\u2011years outcome. Ann Vasc Surg. https:\/\/doi.org\/10.1016\/j.avsg.2019.06.038","journal-title":"Ann Vasc Surg"},{"key":"695_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ejvs.2018.01.019","volume":"55","author":"F Sartipy","year":"2018","unstructured":"Sartipy\u00a0F, Sigvant\u00a0B, Lundin\u00a0F et\u00a0al (2018) Ten year mortality in different peripheral arterial disease stages: a population based observational study on outcome. Eur J Vasc Endovasc Surg 55:529\u2013536","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"695_CR25","doi-asserted-by":"crossref","first-page":"e005891","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","volume":"11","author":"PA Schneider","year":"2018","unstructured":"Schneider\u00a0PA, Laird\u00a0JR, Tepe\u00a0G et al (2018) Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial. Circ Cardiovasc Interv 11:e5891","journal-title":"Circ Cardiovasc Interv"},{"key":"695_CR26","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","volume":"7","author":"P Song","year":"2019","unstructured":"Song\u00a0P, Rudan\u00a0D, Zhu\u00a0Y et\u00a0al (2019) Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health 7:e1020\u2013e1030","journal-title":"Lancet Glob Health"},{"issue":"4","key":"695_CR27","doi-asserted-by":"publisher","first-page":"e004877","DOI":"10.1161\/JAHA.116.004877","volume":"6","author":"MI Spreen","year":"2017","unstructured":"Spreen\u00a0MI, Martens\u00a0JM, Knippenberg\u00a0B et al (2017) Long-term follow-up of the PADI trial: percutaneous transluminal angioplasty versus drug-eluting stents for infrapopliteal lesions in critical limb ischemia. J\u00a0Am Heart Assoc 6(4):e4877. https:\/\/doi.org\/10.1161\/JAHA.116.004877","journal-title":"J Am Heart Assoc"},{"key":"695_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1177\/1526602815583851","volume":"22","author":"S Stahlhoff","year":"2015","unstructured":"Stahlhoff\u00a0S, Donas\u00a0KP, Torsello\u00a0G et al (2015) Drug-eluting vs standard balloon angioplasty for iliac stent restenosis: midterm results. J\u00a0Endovasc Ther 22:314\u2013318","journal-title":"J Endovasc Ther"},{"key":"695_CR29","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jvs.2017.09.015","volume":"67","author":"K Taeymans","year":"2018","unstructured":"Taeymans\u00a0K, Groot Jebbink\u00a0E, Holewijn\u00a0S et al (2018) Three-year outcome of the covered endovascular reconstruction of the aortic bifurcation technique for aortoiliac occlusive disease. J\u00a0Vasc Surg 67:1438\u20131447","journal-title":"J Vasc Surg"},{"key":"695_CR30","doi-asserted-by":"publisher","first-page":"861","DOI":"10.4244\/EIJV10I7A147","volume":"10","author":"M Werner","year":"2014","unstructured":"Werner\u00a0M, Paetzold\u00a0A, Banning-Eichenseer\u00a0U et al (2014) Treatment of complex atherosclerotic femoropopliteal artery disease with a\u00a0self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention 10:861\u2013868","journal-title":"EuroIntervention"},{"key":"695_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1538574416689426","volume":"51","author":"J Zhang","year":"2017","unstructured":"Zhang\u00a0J, Xu\u00a0X, Kong\u00a0J et al (2017) Systematic review and meta-analysis of drug-eluting balloon and stent for infrapopliteal artery revascularization. Vasc Endovascular Surg 51:72\u201383","journal-title":"Vasc Endovascular Surg"},{"key":"695_CR32","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.avsg.2019.02.021","volume":"60","author":"Y Zhou","year":"2019","unstructured":"Zhou\u00a0Y, Lin\u00a0S, Zhang\u00a0Z et al (2019) A network meta-analysis of randomized controlled trials comparing treatment modalities for infrapopliteal lesions in critical limb ischemia. Ann Vasc Surg 60:424\u2013434. https:\/\/doi.org\/10.1016\/j.avsg.2019.02.021","journal-title":"Ann Vasc Surg"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-00695-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-019-00695-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-00695-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T01:12:06Z","timestamp":1664759526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-019-00695-x"}},"subtitle":["Mobilit\u00e4t der Patienten erhalten"],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["695"],"URL":"https:\/\/doi.org\/10.1007\/s00108-019-00695-x","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"assertion":[{"value":"30 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.\u00a0Krankenberg gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}